Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1056431.RAeLKIt6IC_kqlnptvbn9qvCBbbeKOnyNHYH-lAO3jp2k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1056431.RAeLKIt6IC_kqlnptvbn9qvCBbbeKOnyNHYH-lAO3jp2k130_assertion type Assertion NP1056431.RAeLKIt6IC_kqlnptvbn9qvCBbbeKOnyNHYH-lAO3jp2k130_head.
- NP1056431.RAeLKIt6IC_kqlnptvbn9qvCBbbeKOnyNHYH-lAO3jp2k130_assertion wasGeneratedBy ECO_0000203 NP1056431.RAeLKIt6IC_kqlnptvbn9qvCBbbeKOnyNHYH-lAO3jp2k130_provenance.
- NP1056431.RAeLKIt6IC_kqlnptvbn9qvCBbbeKOnyNHYH-lAO3jp2k130_assertion wasDerivedFrom befree-2016 NP1056431.RAeLKIt6IC_kqlnptvbn9qvCBbbeKOnyNHYH-lAO3jp2k130_provenance.
- NP1056431.RAeLKIt6IC_kqlnptvbn9qvCBbbeKOnyNHYH-lAO3jp2k130_assertion SIO_000772 23445613 NP1056431.RAeLKIt6IC_kqlnptvbn9qvCBbbeKOnyNHYH-lAO3jp2k130_provenance.
- NP1056431.RAeLKIt6IC_kqlnptvbn9qvCBbbeKOnyNHYH-lAO3jp2k130_assertion evidence source_evidence_literature NP1056431.RAeLKIt6IC_kqlnptvbn9qvCBbbeKOnyNHYH-lAO3jp2k130_provenance.
- NP1056431.RAeLKIt6IC_kqlnptvbn9qvCBbbeKOnyNHYH-lAO3jp2k130_assertion description "[Here, we show that treatment with the dual phosphoinositide-3-kinase (PI3K)/AKT and mTOR inhibitor BEZ235 attenuated PI3K/AKT and mTOR signaling, as well as induced cell-cycle growth arrest and apoptosis of the cultured human JAK2-V617F-expressing HEL92.1.7 (HEL), UKE1 cells, and primary CD34+ myelofibrosis (MF)-MPN cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1056431.RAeLKIt6IC_kqlnptvbn9qvCBbbeKOnyNHYH-lAO3jp2k130_provenance.